Back to top

Edwards Lifesciences Expands Pediatric Heart Portfolio With Autus Valve Access Study

Edwards Lifesciences Corp. ($EW) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. (EW) has launched the Autus Valve ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Edwards Lifesciences Corporation (EW)